We can't find the internet
Attempting to reconnect
12638.1;12 PFLS-LS
TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS
Résumé
TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS
Textes supplémentaires
Abstract
It was recently discovered at the University of Basel that combining a well known metabolic drug with a drug not previously reported to have any potential for the treatment of cancer led to an unexpected and synergistic anti-tumor effect. We aim to pursue this novel anti-cancer approach to the clinic. Proposed are chemical modifications to optimize one of the combination partners, as well as toxicological and pharmacological studies. In parallel, mechanistic studies, including identification of drug binding/effector genes, will be performed in order to define biomarkers of drug response and guide drug development.
Participants
Michael Hall
Kontaktperson
m.hall@unibas.ch
Universität Basel Michael Hall Klingelbergstrasse 70 4056 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2011-09-30
- Date de fin
- 2014-06-16
- Coûts totaux approuvés
- CHF 681440.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%